Cleveland-based Checkpoint Surgical secures $7.5 million so far in a quest for $10 million to support its intra-surgical nerve detection systems.
Checkpoint Surgical is looking for another $2.5 million to cap off a $10 million equity funding round originally launched in 2011, according to the company’s SEC documents.
The Cleveland medtech maker has raised about $7.5 million so far from 40 unnamed funders. The minimum investment is $9,230, according to a filing.
The Checkpoint Stimulator/Locater stimulates motor nerves so surgeons can avoid damaging them during surgery. The device also helps physicians gauge nerve and muscle health. The device has been on the U.S. market since 2009.
[gview file=”https://orthospinenews.com/wp-content/uploads/2014/08/Checkpoint-Med.pdf” save=”1″]
